People with intellectual or developmental disabilities may be 2.57 times more likely to die of colorectal cancer than those without these disabilities.
New research suggests that review of current prostate cancer screening guidelines may be needed, as MRI frequently fails to detect cancer-indicative lesions, even in men with elevated PSA levels.
Despite growing enthusiasm for this minimally invasive option for some men with prostate cancer, focal therapy is still not FDA-approved for prostate cancer and comes with high out-of-pocket costs.